Artwork

Content provided by ASCO Education and American Society of Clinical Oncology (ASCO). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ASCO Education and American Society of Clinical Oncology (ASCO) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Oncology, Etc. - In Conversation with Dr. David Steensma (Part 1)

23:01
 
Share
 

Manage episode 346202592 series 1429974
Content provided by ASCO Education and American Society of Clinical Oncology (ASCO). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ASCO Education and American Society of Clinical Oncology (ASCO) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this Oncology, Etc. episode, hosts Patrick Loehrer and David Johnson interview hematologist-oncologist and scientist Dr. David Steensma, who currently serves as Head of Global Hematology at Novartis. In Part One of the episode, Dr. Steensma shares about his career journey from astronomy to medicine, and from academia to industry. We’ll also learn about the discovery and significance of a new pre-malignant condition - Clonal Hematopoiesis of Indeterminate Potential (CHIP).

If you liked this episode, please subscribe. Learn more at https://education.asco.org, or email us at

  continue reading

198 episodes

Artwork
iconShare
 
Manage episode 346202592 series 1429974
Content provided by ASCO Education and American Society of Clinical Oncology (ASCO). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ASCO Education and American Society of Clinical Oncology (ASCO) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this Oncology, Etc. episode, hosts Patrick Loehrer and David Johnson interview hematologist-oncologist and scientist Dr. David Steensma, who currently serves as Head of Global Hematology at Novartis. In Part One of the episode, Dr. Steensma shares about his career journey from astronomy to medicine, and from academia to industry. We’ll also learn about the discovery and significance of a new pre-malignant condition - Clonal Hematopoiesis of Indeterminate Potential (CHIP).

If you liked this episode, please subscribe. Learn more at https://education.asco.org, or email us at

  continue reading

198 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide